• Genetic Immunity Press Releases

    To access our corporate press release archive please first select the year and then browse news items by month. Press releases are available as PDF files.

    Forward-looking statements

    These press releases may contain "forward-looking statements" for the purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company's current expectations about its future plans and performance, including statements concerning the impact of marketing strategies, new product introductions and innovation, deliveries of product, sales, earnings, and margins. These forward-looking statements rely on a number of assumptions and estimates which could be inaccurate and which are subject to risks and uncertainties. Actual results could vary materially from those anticipated or expressed in any forward-looking statement made by the Company. The Company disclaims any obligation or intent to update the forward-looking statements in these press releases in order to reflect events or circumstances after the date of these releases.

    To view or print PDF files please download the free Adobe Acrobat Reader.


Jan 29 - Genetic Immunity Licenses 20 cancer immunotheries to Pharmadis JSC [ PDF ]


Dec 18 - Genetic Immuity licenses HIV vaccine technology to Pharmadis JSC [ PDF ]
Dec 5 - Genetic Immuity Presents at Firat Russian-Chinese Congress in Moscow [ PDF ]